Center for Drug Safety and Immunology Archive — Page 1 of 1

Three colleagues pose together in a laboratory workspace, with shelves of boxes and supplies behind them.
October 5, 2026

Vanderbilt Health to lead national consortium on life-threatening drug reactions of the skin

“For too long, patients who survive these reactions have been left without clear answers about why it happened, which medicines are safe, and what the future holds,” said Elizabeth Phillips, MD, who is leading the consortium.

Conceptual biotechnology scene showing gloved laboratory workers, test tubes, a pipette, and overlaid medical graphics including DNA-like molecular structures, human anatomy icons, a heartbeat waveform, charts, and a digital human figure.
September 2, 2026

Millions get wrong genetic test, study finds

A study shows current testing is providing false reassurance about genetic disposition for a rare life-threatening drug reaction.

By Paul Govern
Three-dimensional anatomical cross-section of skin showing hair follicles, epidermis and dermis layers, subcutaneous fat, blood vessels, nerves, and coiled sweat glands.
November 12, 2025

New study reveals long-term impacts on Stevens-Johnson syndrome survivors 

SJS and TEN occur when a medication triggers the immune system to attack the body’s own skin and mucous membranes.

By Kylie Avery
Close-up stylized graphic displaying the words “COVID-19” and “VIRUS” over a dark digital interface with glowing lines, numbers, and circuit-like patterns.
March 18, 2021

Study to assess allergic reactions to COVID vaccines

Vanderbilt University Medical Center is recruiting volunteers for a randomized controlled phase 2 clinical trial to help determine the prevalence of systemic allergic reactions (SARS) to the two-dose COVID-19 mRNA vaccines made by Pfizer-BioNTech and Moderna.

By Bill Snyder